W G Case

739 total citations
29 papers, 573 citations indexed

About

W G Case is a scholar working on Experimental and Cognitive Psychology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, W G Case has authored 29 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Experimental and Cognitive Psychology, 14 papers in Psychiatry and Mental health and 12 papers in Pharmacology. Recurrent topics in W G Case's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (13 papers), Treatment of Major Depression (11 papers) and Sleep and related disorders (6 papers). W G Case is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (13 papers), Treatment of Major Depression (11 papers) and Sleep and related disorders (6 papers). W G Case collaborates with scholars based in United States. W G Case's co-authors include Karl Rickels, Edward E. Schweizer, I Csanalosi, R. Downing, Karl Rickels, David J. Greenblatt, Irwin Lucki, Felipe García‐España, Arthur P. Schless and Paul E. Gordon and has published in prestigious journals such as American Journal of Psychiatry, Psychopharmacology and Clinical Pharmacology & Therapeutics.

In The Last Decade

W G Case

28 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
W G Case United States	15	303	227	171	160	113	29	573
Laura A. Mandos United States	12	300 1.0×	214 0.9×	241 1.4×	88 0.6×	93 0.8×	19	568
R T Owen United Kingdom	8	178 0.6×	210 0.9×	121 0.7×	114 0.7×	93 0.8×	9	583
Malcolm Lader United Kingdom	14	429 1.4×	213 0.9×	104 0.6×	191 1.2×	110 1.0×	19	849
Kirsten Rohde United States	7	140 0.5×	140 0.6×	104 0.6×	153 1.0×	76 0.7×	9	611
Ruby Palmer United States	10	112 0.4×	153 0.7×	98 0.6×	56 0.3×	68 0.6×	14	372
Lawrence Martin United States	9	241 0.8×	264 1.2×	258 1.5×	91 0.6×	48 0.4×	15	775
Christian Barnas Austria	13	78 0.3×	230 1.0×	101 0.6×	69 0.4×	115 1.0×	25	515
John M. Herrera United States	10	131 0.4×	206 0.9×	154 0.9×	120 0.8×	40 0.4×	18	478
S. Argyropoulos United Kingdom	10	465 1.5×	119 0.5×	53 0.3×	376 2.4×	84 0.7×	15	751
P. Tyrer United Kingdom	8	148 0.5×	94 0.4×	68 0.4×	85 0.5×	61 0.5×	18	403

Countries citing papers authored by W G Case

Since Specialization

Citations

This map shows the geographic impact of W G Case's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W G Case with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W G Case more than expected).

Fields of papers citing papers by W G Case

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W G Case. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W G Case. The network helps show where W G Case may publish in the future.

Co-authorship network of co-authors of W G Case

This figure shows the co-authorship network connecting the top 25 collaborators of W G Case. A scholar is included among the top collaborators of W G Case based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W G Case. W G Case is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rickels, Karl, Irwin Lucki, Edward E. Schweizer, Felipe García‐España, & W G Case. (1999). Psychomotor Performance of Long-Term Benzodiazepine Users Before, During, and After Benzodiazepine Discontinuation. Journal of Clinical Psychopharmacology. 19(2). 107–113. 32 indexed citations

Rickels, Karl, Edward E. Schweizer, W G Case, et al.. (1998). Nefazodone in Major Depression. Journal of Clinical Psychopharmacology. 18(2). 145–153. 12 indexed citations

Schweizer, Edward E., et al.. (1995). Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome. Psychopharmacology. 117(4). 424–429. 41 indexed citations

Rickels, Karl, Edward E. Schweizer, & W G Case. (1992). BENZODIAZEPINES: TOLERANCE AND WITHDRAWAL: THE CLINICIANʼS POINT OF VIEW. Clinical Neuropharmacology. 15. 102A–103A. 2 indexed citations

Rickels, Karl, et al.. (1991). Long-term benzodiazepine users 3 years after participation in a discontinuation program. American Journal of Psychiatry. 148(6). 757–761. 67 indexed citations

Schweizer, Edward E., W G Case, & Karl Rickels. (1989). Benzodiazepine dependence and withdrawal in elderly patients. American Journal of Psychiatry. 146(4). 529–531. 67 indexed citations

Rickels, Karl, W G Case, & Edward E. Schweizer. (1988). The drug treatment of anxiety and panic disorder. Stress Medicine. 4(4). 231–239. 5 indexed citations

Rickels, Karl, et al.. (1986). One-Year Follow-up of Anxious Patients Treated with Diazepam. Journal of Clinical Psychopharmacology. 6(1). 32???35–32???35. 36 indexed citations

Rickels, Karl, et al.. (1986). Brotizolam, a triazolothienodiazepine, in insomnia. Clinical Pharmacology & Therapeutics. 40(3). 293–299. 8 indexed citations

10.

Rickels, Karl, W G Case, R. Downing, & Andrew Winokur. (1985). Indications and contraindications for chronic anxiolytic treatment: is there tolerance to the anxiolytic effect?. PubMed. 40. 193–204. 9 indexed citations

11.

Rickels, Karl, W G Case, R. Downing, Ruth Dixon, & Rafael Fridman. (1984). Diazepam and Desmethyldiazepam Plasma Concentrations in Chronic Anxious Outpatients. Pharmacopsychiatry. 17(2). 44–49. 4 indexed citations

12.

Rickels, Karl & W G Case. (1982). Trazodone in depressed outpatients. Journal of Clinical Psychopharmacology. 2(6). 428–428. 2 indexed citations

13.

Rickels, Karl, et al.. (1980). Relapse after Short-Term Drug Therapy in Neurotic Outpatients. International Pharmacopsychiatry. 15(3). 186–192. 19 indexed citations

14.

Rickels, Karl, et al.. (1978). Diazepam and Halazepam in Anxiety:some Prognostic Indicators. International Pharmacopsychiatry. 13(2). 118–125. 5 indexed citations

15.

Rickels, Karl, et al.. (1977). Prazepam in anxiety: A controlled clinical trial. Comprehensive Psychiatry. 18(3). 239–249. 14 indexed citations

16.

Rickels, Karl, et al.. (1976). Lorazepam and Diazepam in Anxious Outpatients. International Pharmacopsychiatry. 11(2). 93–101. 5 indexed citations

17.

Rickels, Karl, et al.. (1974). Chlormezanone in Anxiety : A Drug Rediscovered?. American Journal of Psychiatry. 131(5). 592–595. 4 indexed citations

18.

Rickels, Karl, et al.. (1974). Amitriptyline in Anxious-Depressed Outpatients: A Controlled Study. American Journal of Psychiatry. 131(1). 25–30. 33 indexed citations

19.

Rickels, Karl, et al.. (1969). Doxepin and diazepam in general practice and hospital clinic neurotic patients: A collaborative controlled study. Psychopharmacology. 15(4). 265–279. 30 indexed citations

20.

Case, W G, et al.. (1969). Diphenylhydantoin in Neurotic Anxiety. American Journal of Psychiatry. 126(2). 254–255. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact